DKK1, for example, has been recently reported by our group to play an important role in the development of osteolytic lesions in multiple myeloma (Tian et al, 2003), but its possible role in USPC pathogenesis and/or progression has not been elucidated. This evidence concerns the gene DKK1 and plasma cell myeloma.